134 Grants (Page 4 of 6)
1999
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0289), 12/01/1998 -- 11/30/1999
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0289), 12/01/1998 -- 11/30/1999
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0289), 12/01/1998 -- 11/30/1999
 
PHASE II STUDY OF THE PROLONGATION OF VIROLOGIC SUCCESS AND OPTIONS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0636), 12/01/1998 -- 11/30/1999
 
PHASE II STUDY OF THE PROLONGATION OF VIROLOGIC SUCCESS AND OPTIONS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0636), 12/01/1998 -- 11/30/1999
 
PHASE II STUDY OF THE PROLONGATION OF VIROLOGIC SUCCESS AND OPTIONS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0636), 12/01/1998 -- 11/30/1999
 
RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF INDINAVIR SULFATE (IDV)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0545), 12/01/1998 -- 11/30/1999
 
RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF INDINAVIR SULFATE (IDV)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0545), 12/01/1998 -- 11/30/1999
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0620), 12/01/1998 -- 11/30/1999
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0620), 12/01/1998 -- 11/30/1999
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0620), 12/01/1998 -- 11/30/1999
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0630), 12/01/1998 -- 11/30/1999
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0630), 12/01/1998 -- 11/30/1999
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0630), 12/01/1998 -- 11/30/1999
1998
ANTIVIRAL ACTIVITY AND RESISTANCE OF LAMIVUDINE IN COMBINATION WITH DDI OR D4T
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0533), 12/01/1997 -- 11/30/1998
 
COMPARISON OF THE VIROLOGIC EFFICACY OF NULFINAVIR/DMP 266 IN COMBINATION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0628), 12/01/1997 -- 11/30/1998
 
D4T VS ZDV PLUS D4T VS ZDV PLUS DDI IN HIV INFECTED PATIENTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0509), 12/01/1997 -- 11/30/1998
 
INFLUENCE OF RISK FOR DISEASE PROGRESSION ON RESPONSE TO ANTIRETROVIRAL THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0529), 12/01/1997 -- 11/30/1998
 
NUCLEOSIDE THERAPY FOR ADVANCED HIV DISEASE WITH PRIOR NUCLEOSIDE THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0396), 12/01/1997 -- 11/30/1998
 
OPEN LABEL TREATMENT OF HIV INFECTED SUBJECT WITH TIMUNOX
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0527), 12/01/1997 -- 11/30/1998
 
PATIENT EVALUATION FOR POTENTIAL AIDS CLINICAL TRIAL PARTICIPANTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0289), 12/01/1997 -- 11/30/1998
 
PHASE II STUDY OF THE PROLONGATION OF VIROLOGIC SUCCESS AND OPTIONS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0636), 12/01/1997 -- 11/30/1998
 
RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF INDINAVIR SULFATE (IDV)
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0545), 12/01/1997 -- 11/30/1998
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0620), 12/01/1997 -- 11/30/1998
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-26-0630), 12/01/1997 -- 11/30/1998